Secrets and Lies in a Silicon Valley Startup
Hardcover, 339 pages
English language
Published Dec. 4, 2018 by Knopf.
The full inside story of the breathtaking rise and shocking collapse of a multibillion-dollar startup, by the prize-winning journalist who first broke the story and pursued it to the end in the face of pressure and threats from the CEO and her lawyers.
In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup "unicorn" promised to revolutionize the medical industry with a machine that would make blood tests significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at $9 billion, putting Holmes's worth at an estimated $4.7 billion. There was just one problem: The technology didn't work.
For years, Holmes had been misleading investors, FDA officials, and her own employees. When Carreyrou, working at The Wall Street Journal, got a tip from …
The full inside story of the breathtaking rise and shocking collapse of a multibillion-dollar startup, by the prize-winning journalist who first broke the story and pursued it to the end in the face of pressure and threats from the CEO and her lawyers.
In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup "unicorn" promised to revolutionize the medical industry with a machine that would make blood tests significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at $9 billion, putting Holmes's worth at an estimated $4.7 billion. There was just one problem: The technology didn't work.
For years, Holmes had been misleading investors, FDA officials, and her own employees. When Carreyrou, working at The Wall Street Journal, got a tip from a former Theranos employee and started asking questions, both Carreyrou and the Journal were threatened with lawsuits. Undaunted, the newspaper ran the first of dozens of Theranos articles in late 2015. By early 2017, the company's value was zero and Holmes faced potential legal action from the government and her investors. Here is the riveting story of the biggest corporate fraud since Enron, a disturbing cautionary tale set amid the bold promises and gold-rush frenzy of Silicon Valley.
This reads like an unlikely plot in a fictional crime novel with the main characters using increasingly desperate tactics to cover up their escalating crimes.
Sadly, many companies in Silicon Valley have used similar practices in pursuit of what start out as laudable goals and gradually become sinister and harmful.
Theranos' main difference is that they were caught.
An expertly crafted account of the woman who girlbossed so hard she accidentally committed multiple counts of fraud and put millions of peoples health at risk.
Investigative journalism at it’s best. The book is excellent, readable, clear and logical. The question I kept asking as I read this was “What were they thinking?” When someone perpetrates a massive and clear fraud in public I am always amazed that they somehow convince themselves they won’t get caught. I don’t believe Elizabeth Holmes was a hapless victim of Sunny Balwani, or of structural sexism. it will be interesting to see what the jury thinks.
fascinating story, couldn't put it down (read it faster than anything i've read in a long time), but i do wish the book had spent some time dissecting the conditions that could allow this to happen (silicon valley culture, state of regulations, etc). a great read in any case.
Brilliant investigative journalism!
